chr7-39339688-CCAG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001370959.1(POU6F2):c.674_676del(p.Gln225del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00547 in 1,416,950 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 0 hom. )
Consequence
POU6F2
NM_001370959.1 inframe_deletion
NM_001370959.1 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.10
Genes affected
POU6F2 (HGNC:21694): (POU class 6 homeobox 2) This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001370959.1
BP6
Variant 7-39339688-CCAG-C is Benign according to our data. Variant chr7-39339688-CCAG-C is described in ClinVar as [Benign]. Clinvar id is 3060981.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00609 (7702/1265678) while in subpopulation AMR AF= 0.0208 (748/36048). AF 95% confidence interval is 0.0195. There are 0 homozygotes in gnomad4_exome. There are 4369 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd4 at 50 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU6F2 | NM_001370959.1 | c.674_676del | p.Gln225del | inframe_deletion | 5/10 | ENST00000518318.7 | NP_001357888.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU6F2 | ENST00000518318.7 | c.674_676del | p.Gln225del | inframe_deletion | 5/10 | 1 | NM_001370959.1 | ENSP00000430514 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000331 AC: 50AN: 151164Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
50
AN:
151164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0295 AC: 4811AN: 163196Hom.: 0 AF XY: 0.0307 AC XY: 2725AN XY: 88804
GnomAD3 exomes
AF:
AC:
4811
AN:
163196
Hom.:
AF XY:
AC XY:
2725
AN XY:
88804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00609 AC: 7702AN: 1265678Hom.: 0 AF XY: 0.00699 AC XY: 4369AN XY: 625128
GnomAD4 exome
AF:
AC:
7702
AN:
1265678
Hom.:
AF XY:
AC XY:
4369
AN XY:
625128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000331 AC: 50AN: 151272Hom.: 0 Cov.: 32 AF XY: 0.000298 AC XY: 22AN XY: 73902
GnomAD4 genome
AF:
AC:
50
AN:
151272
Hom.:
Cov.:
32
AF XY:
AC XY:
22
AN XY:
73902
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
POU6F2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 02, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at